Figure S1 from Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death

A. A549, PC9 and NCI-H3122 cells were treated with trametinib, erlotinib and ceritinib, respectively, either alone or in combination with indicated inhibitors. B. HCC827, NCI-H358, HCC44 and NCI-1648 were treated with erlotinib, trametinib or crizotinib as indicated.